Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Most Compelling Innovation Developments Somewhat recently07.07.2023 - 2China’s new condom tax will prove no effective barrier to country’s declining fertility rate15.01.2026
- 3Merz visit highlights new strategic, and strained, Germany-Israel bond07.12.2025
- 4Electric Vehicles for Eco-Accommodating Driving06.06.2024
- 5The most effective method to Perceive the Early Side effects of Cellular breakdown in the lungs17.10.2023
- Opening Monetary Information: Your Exhaustive Manual for Finding out about Individual budget
- Top Fascinating Organic products: Which One Might You Want to Attempt?
- Jason Kelce opens about wife Kylie Kelce's past pregnancy loss
- Hostile to Maturing Skincare Items to Rejuvenate Your Skin
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- Closets for Your Room: Plan and Utility Features
- When fake data is a good thing – how synthetic data trains AI to solve real problems
- Your big brain makes you human – count your neurons when you count your blessings
- Astrophotographer captures rare footage of the Hubble Telescope crossing the sun (video)
